Metadon

Methadone, the active ingredient in Metadon, is a synthetic opioid presented as an oral formulation for oral use. It is used to treat opioid dependence and chronic pain in adult patients.

GNH USA supplies Metadon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metadon is a synthetic opioid that acts on the opioid receptor system to manage dependence and pain.

Opioid dependence: helps maintain abstinence and reduces illicit opioid use. Chronic pain: provides long‑acting analgesia for severe persistent pain. Opioid withdrawal: alleviates acute withdrawal symptoms during detoxification.

Methadone may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Constipation: reduced bowel motility. - Drowsiness: increased sedation. - Nausea: upset stomach and possible vomiting. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing that can be life‑threatening. - QT interval prolongation: risk of cardiac arrhythmias. - Severe hypotension: marked drop in blood pressure.

When prescribing or dispensing Metadon, several safety considerations are essential.

Assess cardiac risk: obtain baseline ECG and monitor QT interval. Monitor respiratory function: watch for signs of depression, especially after dose changes. Adjust dose in hepatic impairment: reduce dosage as liver function declines. Avoid use in acute severe asthma: risk of bronchospasm. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Methadone interacts with several drug classes; careful management is required.

Major Interactions (Avoid): - CNS depressants (e.g., benzodiazepines): increased risk of respiratory depression. - MAO inhibitors: can precipitate severe hypotension. - QT‑prolonging agents (e.g., certain antiarrhythmics): additive cardiac risk. - Strong CYP3A4 inhibitors (e.g., ketoconazole): raise methadone levels. - Other opioids: synergistic sedation and respiratory effects.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin): may lower methadone concentrations. - Alcohol: enhances sedative effects and respiratory depression.